Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085358
Status:
COMPLETED
Last Update Posted:
2019-07-22
First Post:
2004-06-10
Brief Title:
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel Carboplatin and Paclitaxel in Treating Patients With Stage II Stage III or Stage IV Ovarian Epithelial Fallopian Tube or Primary Peritoneal Cavity Carcinoma Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
NCI-2009-00619
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Gynecologic Oncology Group | NETWORK |